Ecolab Q3 Earnings: Beats On EPS, Misses On Sales, Revises Annual EPS Forecast & More (CORRECTED)
Written by Emily J. Thompson, Senior Investment Analyst
Source: Benzinga
Ecolab's Financial Performance: Ecolab Inc reported a 1% year-on-year sales growth to $3.999 billion in Q3, missing estimates, while adjusted EPS of $1.83 exceeded expectations. The company saw varied performance across segments, with Global Healthcare & Life Sciences declining by 18%.
Future Outlook: Ecolab revised its FY24 adjusted EPS outlook to $6.60 – $6.70 and anticipates Q4 adjusted EPS between $1.75 – $1.85, slightly below analyst estimates.
Analyst Views on ECL
Wall Street analysts forecast ECL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ECL is 294.64 USD with a low forecast of 248.00 USD and a high forecast of 315.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Analyst Rating
12 Buy
5 Hold
0 Sell
Moderate Buy
Current: 281.480
Low
248.00
Averages
294.64
High
315.00
Current: 281.480
Low
248.00
Averages
294.64
High
315.00
About ECL
Ecolab Inc. is engaged in offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. The Company’s Global Industrial segment provides water treatment and process applications, and cleaning and sanitizing solutions primarily to large industrial customers within the manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. Its Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education and retail industries. Its Global Healthcare & Life Sciences segment provides specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries. Its Global Pest Elimination segment provides services designed to detect, prevent, and eliminate pests, such as rodents and insects.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
